Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 149 Breast Neoplasms 38 Prostatic Neoplasms 31 Insulin Resistance 30 Obesity 23 Endometrial Neoplasms 15 Neoplasms 14 Infertility 14 Colorectal Neoplasms 13 Pancreatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Hyperandrogenism 8 Glioblastoma 8 Diabetes Mellitus 8 Squamous Cell Carcinoma of Head and Neck 7 Metabolic Syndrome 7 Melanoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Head and Neck Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4

Interventions

Everolimus 8 Temozolomide 7 Sunitinib 6 Specimen Handling 4 Octreotide 4 Magnetic Resonance Spectroscopy 4 Fluorouracil 4 Capecitabine 4 lutetium Lu 177 dotatate 3 Leucovorin 3 sargramostim 2 montanide ISA 51 2 incomplete Freund's adjuvant 2 cabozantinib 2 Thalidomide 2 Streptozocin 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Colony-Stimulating Factors 2 Bevacizumab 2 surufatinib 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pentetreotide 1 pasireotide 1 nimotuzumab 1 napabucasin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenoma, Islet Cell × Metformin × Clear all

NCT02294006 2021-09-09

MetNET1

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡